Browse > Article
http://dx.doi.org/10.3347/kjp.2008.46.3.175

Successful Treatment of Lupoid Cutaneous Leishmaniasis with Glucantime and Topical Trichloroacetic Acid (A Case Report)  

Nilforoushzadeh, Mohamad Ali (Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences)
Sadeghian, Giti (Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences)
Jaffary, Fariba (Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences)
Ziaei, Hengameh (Medical School, Isfahan University of Medical Sciences)
Shirani-Bidabad, Liela (Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences)
Mahzoni, Parvin (Department of Pathology, Isfahan University of Medical Sciences)
Publication Information
Parasites, Hosts and Diseases / v.46, no.3, 2008 , pp. 175-177 More about this Journal
Abstract
Lupoid leishmaniasis is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and a chronic relapsing course, mostly caused by infection with Leishmania tropica. In this clinical form, 1-2 yr after healing of the acute lesion, new papules and nodules appear at the margin of the remaining scar. Herein, we describe a case of this clinical form that was resistant to 2 courses of treatments: systemic glucantime and then a combination therapy with allopurinol and systemic glucantime. However, marked improvement was seen after a combination therapy with topical trichloroacetic acid solution (50%) and systemic glucantime, and there were no signs of recurrence after 1 yr of follow-up.
Keywords
Leishmanis tropica; cutaneous leishmaniasis; trichloroacetic acid;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Christopherson JB. Lupoid leishmaniasis; a leishmaniasis of the skin resembling lupus vulgaris; hitherto unclassified. Br J Dermatol 1923; 35: 123-131   DOI
2 Ardehali S, Sodeiphy M, Haghighi P, Rezai H, Vollum D. Studies on chronic (lupoid) leishmaniasis. Ann Trop Med Parasitol 1980; 74: 439-445   DOI   PUBMED
3 Bridenstine JB, Dolezal JF. Standarizating chemical peel solusion formulations to avoid mishaps. Great fluctuation in actual concentrations of trichloroacetic acid. J Dermatol surg Oncol 1994; 20: 813-816   DOI   PUBMED
4 Azadeh B, Samad A, Ardehali S. Histological spectrum of cutaneous leishmaniasis due to Leishmania tropica. Trans Roy Soc Trop Med Hyg 1985; 79: 631-636   DOI   ScienceOn
5 Momeni AZ, Aminjavaheri M. Treatment of recurrent cutaneous leishmaniasis. Int J Dermatol 1995; 34: 129-133   DOI   ScienceOn
6 Bassiouny A. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1983; 109: 617-619   DOI   ScienceOn
7 Richard B, Odom WD, Berger TG. Parasitic infections, stings, and bites. In: Odom RB, James WD, Berger TG, Andrew's Diseases of the Skin: Clinical Dermatology. 9th ed. Philadelphia, USA. W. B. Saunders Co. 2000, p 528
8 Nilfrousihzadeh MA, Jaffray F, Reiszadeh MR, Ansari N. The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis. Int J Dermatol 2006; 45: 989-991   DOI   ScienceOn
9 Herrmann A, Wohlrab J, Sudeck H, Burchard GD, Marsch WC. Chronic lupoid leishmaniasis: a rare differential diagnosis in Germany for erythematous infiltrative facial plaques. Hautarzt 2007; 58: 256-260   DOI
10 Ganor S. The treatment of leishmaniasis recidivans with local injections of amphotericin B. Dermatol Int 1967; 6: 141-143   DOI
11 Babajev KB, Babajev OG, Korepanov VI. Treatment of cutaneous leishmaniasis using a carbon dioxide laser. Bull WHO 1991; 69: 103-106   PUBMED
12 Gurel MS. Ulukanligil M, Ozbilge H. Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000). Int J Dermatol 2002; 41: 32-37   DOI   ScienceOn
13 Asilian A, Iraji F, Hedaiti HR, Siadat AH, Enshaieh S. Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): a case series of 24 patients. Dermatol Online J 2006; 12: 3   PUBMED
14 Butler PG. Levamisole and immune response phenomena in cutaneous leishmaniasis. J Am Acad Dermatol 1982; 6: 1070-1077   DOI   ScienceOn
15 Nilforoushzadeh MA, Jaffary F. Reiszadeh, MR. Comparative effect of topical trichloroacetic acid and intralesional meglumine antimonate in the treatment of acute cutaneous leishmaniosis. Int J Pharmacol 2006; 2: 633-636   DOI
16 Jones J, Bowling J, Watson J, Vega-Lopez F, White J, Higgins E. Old world cutaneous leishmaniasis infection in children: a case series. Arch Dis Child 2005; 90: 530-531   DOI   ScienceOn
17 Dogra J, Lal BB, Misra SN. Dapsone in the treatment of cutaneous leishmaniasis. Int J Dermatol 1986; 25: 398-400   DOI